Pharmacy Times

OCTOBER 11, 2024

Panelists discuss how the introduction of triplet therapy prior to transplant in studies like IFM 2009 and DETERMINATION shifted the clinician mindset toward more intensive induction regimens, leading to a focus on achieving deeper responses and longer progression-free survival as primary goals of therapy for newly diagnosed multiple myeloma patients. (..)

Leads 26

Leads Patients 26

World of DTC Marketing

MAY 26, 2021

Humira’s net price—which subtracts discounts and rebates—increased by 110% between 2009 and 2018, from $16,663 per year to $35,041 per year. billion in “Humira Research & Development” expenditures between 2009 and 2018—approximately 4.2% of the company’s Humira worldwide net revenue over that period. The post 470% price increases.

Competition 180

Competition Marketing Government Patients 180

World of DTC Marketing

JANUARY 10, 2022

This study included 63 of 355 new therapeutic drugs and biologic agents approved by the US Food and Drug Administration between 2009 and 2018. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3

Food and Drug Administration 213

Food and Drug Administration Pharma Marketing Food 213

PM360

AUGUST 17, 2022

The Trailblazer Awards were established in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. The finalists are in for PM360’s 14 th annual Trailblazer Awards.

Education 105

Education Marketing Pharma Media 105

Pharmaceutical Technology

JUNE 23, 2022

It was discovered by Incyte and licensed to Novartis in 2009. A kinase inhibitor, Tabrecta acts on MET. The latest development comes after the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) provided a positive opinion in April this year.

Medicine 105

Medicine Leads Patients Pharmaceutical 105

European Pharmaceutical Review

FEBRUARY 23, 2023

Monocyte-activation test (MAT), added in 2009, provided an in-vitro alternative to the RPT. Therefore, a test covering all types of pyrogens is required to confirm the absence of non-endotoxin pyrogens. General chapter 2.6.30. It can detect both endotoxin and non-endotoxin pyrogens.

Consulting 98

Consulting Pharmaceutical 98

World of DTC Marketing

DECEMBER 18, 2020

healthcare system saved almost $2 trillion from 2009 to 2019 in healthcare costs due to generic drugs. When both brand and generic versions of the prescribed medication were available, the generic was chosen 97 percent of the time, resulting in significant patient savings.

Pharma 155

Pharma Prescription Media Healthcare 155

World of DTC Marketing

FEBRUARY 4, 2021

As early as 2009, Merck knew of more than 200 reports of depression, including suicidal thoughts, in men taking Propecia, according to an internal “risk management” assessment from that year. Annual U.S. prescriptions of finasteride, as the drug is known, for hair loss increased to over 2.4

Pharma 180

Pharma Food and Drug Administration Side effects Safety 180

PharmaTimes

DECEMBER 18, 2023

Scientists recruited 49 volunteers with mild cognitive impairment (MCI) and 45 healthy adults aged 55 years and older who had previously undergone an MRI to measure changes in brain structure and two positron emission tomography (PET) scans of their brains at Johns Hopkins between 2009 and 2022.

Transportation 88

Transportation Medicine Recruitment Patients 88

Medical Device Success

NOVEMBER 17, 2010

Perhaps your company is struggling in the wake of the 2009 economic downturn. This commitment will spread to the employees that aren’t part of the planning team. Employees that see a plan in place will feel more secure about this small company they are working for.

Recruitment 100

Recruitment Sales Media Marketing 100

pharmaphorum

JANUARY 24, 2023

Over the last 25 years, the headcount in the medicines manufacturing sector has fallen by 7,000 and since 2009 production volumes have fallen by nearly a third (29%), suggesting “faltering attractiveness” of the UK for manufacturing. Established trends are unfortunately firmly in the wrong direction.

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

Government 59

Government Specialization Physicians Education 59

European Pharmaceutical Review

JANUARY 25, 2024

“Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.” Article 63 EMA (29 January 2020). Key principles for the use of electronic product information for EU medicines” Breinstrup T.

Healthcare 98

Healthcare Healthcare Safety Electronics 98

PM360

AUGUST 24, 2023

Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. The finalists are in for PM360’s 15 th annual Trailblazer Awards.

Education 98

Education Marketing Media Patients 98

pharmaphorum

OCTOBER 19, 2022

Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009. Dr Paul Tunnah, chief content officer and managing director UK, Healthware (moderator). The post How the Digital Patient Experience is Shaping the Future of Pharma appeared first on.

Patients 98

Patients Pharma Management Sales technology 98

pharmaphorum

OCTOBER 28, 2022

Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009. Dr Paul Tunnah, chief content officer and managing director UK, Healthware (moderator).

Medicine 122

Medicine Management Marketing Leads 122

European Pharmaceutical Review

APRIL 10, 2023

A 2009 study by Eigner et al. On the other hand, the Shimadzu MS showed a high-confidence identification for 639 isolates (88.8 All the high-confidence MS identifications were accurate at the genus level. on 1116 routine isolates representing the main bacterial groups encountered in the clinical microbiology laboratory, showed 95.2

Media 127

Media Healthcare Healthcare Pharmaceutical 127

Pharmaceutical Technology

JULY 29, 2022

Abilify (aripiprazole) , marketed by Bristol Myers Squibb and Otsuka Pharmaceuticals, was approved in 2009 for irritability treatment in six to 17-year-old children with ASD. Generic versions of both drugs are now available.

Side effects 105

Side effects Medical Pharmaceutical Management 105

Clarivate

OCTOBER 31, 2023

It shows an acceleration in published research output, which increased five-fold between 2009 and 2021, well outpacing the U.S. Our latest ISI report, China’s research landscape , draws on Web of Science data to reveal the trajectory and dynamics of China’s research landscape. Our analysis suggests this trajectory is likely to continue.

Engineering 75

Engineering Leads Networking Electronics 75

Med Device Careers

JULY 19, 2021

Since founding PrepMD in 2009, Matt has overseen an organization that has graduated over 500 qualified medical device candidates into the workforce and has expanded business operations to include contract staffing and direct placement services as well as a rapidly expanding cardiac device remote monitoring division.

Medical 52

Medical Training Recruitment Healthcare 52

Salesforce

AUGUST 2, 2022

share-price gain during the 2007-2009 downturn, while the broader stock market declined by 35%, according to an AARP study. share-price gain during the 2007-2009 downturn, while the broader stock market declined by 35%. Inclusive companies (with a diverse workforce across age, gender, race, sexuality, and ability), posted a 14.4%

Training 98

Training Recruitment Marketing Management 98

Pharma Marketing Network

JULY 17, 2023

Along the way, he has worked for the likes of Havas, Cushman & Wakefield and began a deep dive into the healthcare arena in 2009 when he joined Inventiv Health as Head of Digital & innovation. He joined Ogilvy in 2014, as the Chief Digital Officer for Ogilvy CommonHealth, the specialist health care agency within the Ogilvy Group.

Consulting 52

Consulting Education Networking Healthcare 52

pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. In the last 15 years, there has been a noticeable shift towards many prominent players effectively outsourcing innovation to start-ups due to the increasing cost of R&D.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

Pharmaceutical Technology

SEPTEMBER 22, 2022

Since 2009, Meiji has marketed tebipenem HBr in Japan. Under the deal, GSK will obtain an exclusive licence for the development and marketing of tebipenem pivoxil HBr in all countries. This licence will exclude Japan and certain Asian countries, which will be retained by Spero partner Meiji Seika Pharma.

Food and Drug Administration 59

Food and Drug Administration Marketing FDA Media 59

European Pharmaceutical Review

FEBRUARY 22, 2023

Characterization of natural wax esters by MALDI-TOF mass spectrometry, J Mass Spectrom , 2009, 44, 101–110. An overview, J Incl Phenom Macrocycl Chem , 2009, 65, 237-248. Vrkoslav V, Míková R, Cvačka J. Tran A, Monreal IA, et al. 2021, 32, 289–300. Norkus E, Metal ion complexes with native cyclodextrins. Chen Y, Zou Z, Dai X, et al.

Food 98

Food Electronics Pharmaceutical Medical 98

pharmaphorum

JANUARY 4, 2023

The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008. According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas’ top products. It is sold as Rapiscan in Europe by GE Healthcare.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

European Pharmaceutical Review

DECEMBER 5, 2024

Aulton’s Pharmaceutics: The Design and Manufacture of Medicines (5th ed.). Lachman L, Lieberman H A, Kanig J L. The Theory and Practice of Industrial Pharmacy (4th ed.). CBS Publishers & Distributors. Rowe R C, Sheskey P J, Quinn M E. Handbook of Pharmaceutical Excipients (6th ed.). Pharmaceutical Press.

Pharmaceutical 52

Pharmaceutical Manufacturing Leads Medicine 52

MedReps

OCTOBER 25, 2022

According to a study done back in 2009 , physicians had some interesting things to say about the medical sales representatives they encountered: 87% of those interviewed wanted more clinical studies and fewer glossy brochures. This will help them realize just how useful and well-tested the products are. Why Does Evidence-Based Selling Work?

Medical sales 86

Medical sales Sales Medical Physicians 86

pharmaphorum

JANUARY 3, 2023

ReNeuron was founded in the late 1990s and floated in 2000, but saw slow progress with its stem cell therapies, with approval to start clinical testing arriving in 2009 after the UK cleared a trial of a stroke therapy. Isted joined ReNeuron as chief financial officer in 2021, before stepping up to the top job for just a few months.

Biopharma 59

Biopharma Pharma Leads Management 59

Pharmacy Times

JULY 18, 2022

Influenza viruses typically circulate in the Northern Hemisphere during the winter and spring, but they occasionally can circulate more during the summer months, as did the 2009 H1N1 pandemic strain.

26

26

PM360

OCTOBER 3, 2023

Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. PM360 has announced the winners of its 15 th annual Trailblazer Awards.

Education 122

Education Marketing Media Pharmaceutical 122

European Pharmaceutical Review

SEPTEMBER 14, 2023

In 2001 and 2007, through 2009, the economy was hit hard. As a result of the economic uncertainty, 75 percent of life sciences company executives have experienced negative impacts on their business in the current macroeconomic climate. 1 We can only learn from the past and try not to repeat history.

Manufacturing 98

Manufacturing Management Engineering Pharmaceutical 98

pharmaphorum

SEPTEMBER 26, 2022

Lexiscan was originally developed by CV Therapeutics, which licensed rights to the drug to Astellas shortly before the Japanese pharma launched a hostile bid for the company – thwarted when it was acquired by Gilead in 2009. The post Astellas facing generics to big-selling Lexiscan product in US appeared first on.

Pharmacology 52

Pharmacology FDA Marketing Pharma 52

Pharmaceutical Technology

APRIL 12, 2023

Since the inception of the ACA, changes in cancer screening among privately insured individuals show an overall increase in colorectal cancer screening tests.

Insurance 52

Insurance Leads Medical 52

Nixon Gwilt Law

FEBRUARY 27, 2023

Notably, this rulemaking does not propose to implement the “special registration” for telemedicine providers the DEA has been promising since the Ryan Haight Act passed in 2009. Instead, it would create a new regulatory category of the “practice of telemedicine.”

Prescription 105

Prescription Medical Patients Specialization 105

pharmaphorum

AUGUST 24, 2022

A federal judge has ruled that a jury trial will be needed to resolve allegations that Indivior attempted to preserve a monopoly by switching to a sublingual film formulation of Suboxone (buprenorphine/naloxone) in 2009 from an older pill version of the product.

Competition 52

Competition Marketing Healthcare Healthcare 52

pharmaphorum

SEPTEMBER 27, 2022

The suit claimed that Biogen paid millions of dollars to doctors in the form of speaker honoraria, training fees, consulting fees, and meals to induce them to prescribe the MS drugs Avonex (interferon-beta-1a), Tysabri (natalizumab), and Tecfidera (dimethyl fumarate) between 2009 and 2014.

Government 45

Government Doctors Consulting Training 45